Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
6.–10. rezultāts no 100.
377. lappuse
... milliliter ; W = Milligrams of water ; VT - Milliliters used ; of Karl Fischer reagent VA Milliliters of Karl Fischer reagent equivalent to the 20 milliliters of solvent A , determined as directed in paragraph ( c ) ( 3 ) of this ...
... milliliter ; W = Milligrams of water ; VT - Milliliters used ; of Karl Fischer reagent VA Milliliters of Karl Fischer reagent equivalent to the 20 milliliters of solvent A , determined as directed in paragraph ( c ) ( 3 ) of this ...
378. lappuse
... Milliliters of Karl Fischer reagent used ; VM - Milliliters of methanol solution used ; f - Milliliters of Karl Fischer reagent equiv- alent to each milliliter of methanol solu- tion determined as directed in paragraph ( c ) ( 2 ) of ...
... Milliliters of Karl Fischer reagent used ; VM - Milliliters of methanol solution used ; f - Milliliters of Karl Fischer reagent equiv- alent to each milliliter of methanol solu- tion determined as directed in paragraph ( c ) ( 2 ) of ...
381. lappuse
... milliliter. Antibiotic Diluent ( solution num- ber as listed in §436.101 ( a ) ) Final concentration in units or milligrams of activity per milliliter of sample 1.25 mg.2 Bacampicillin hydrochloride None ...... do Cephalexin ...... do ...
... milliliter. Antibiotic Diluent ( solution num- ber as listed in §436.101 ( a ) ) Final concentration in units or milligrams of activity per milliliter of sample 1.25 mg.2 Bacampicillin hydrochloride None ...... do Cephalexin ...... do ...
384. lappuse
... milliliters of 0.15N nitric acid , and di- lute with water to a volume of 1,000 milliliters . Prepare and store this solu- tion in glass containers free from solu- ble lead salts . ( 5 ) Standard lead solution . Dilute a 10- milliliter ...
... milliliters of 0.15N nitric acid , and di- lute with water to a volume of 1,000 milliliters . Prepare and store this solu- tion in glass containers free from solu- ble lead salts . ( 5 ) Standard lead solution . Dilute a 10- milliliter ...
391. lappuse
... milliliters of glacial acetic acid and sufficient dis- tilled water to make 2 liters ) to obtain a known concentration of 0.01 to 0.03 milligram of cephradine per milliliter . ( ii ) Preparation of sample solution . Fil- ter the sample ...
... milliliters of glacial acetic acid and sufficient dis- tilled water to make 2 liters ) to obtain a known concentration of 0.01 to 0.03 milligram of cephradine per milliliter . ( ii ) Preparation of sample solution . Fil- ter the sample ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning